Ticker

Earnings Call Scheduled for 9 : 3 0 p.m. ET  on March 15,  202 6 MILPITAS, Calif.

MILPITAS, Calif.--(BUSINESS WIRE)-- #DiscoverAmazing--Amazfit, a leading global smart wearable brand owned by Zepp Health, today announced the Amazfit Active 3 Premium, a compact, 4-button smartwatch designed as an entry point into structured running and hybrid training. Made for athletes building consistency across different forms of training, the Active 3 Premium supports road running and hybrid routines that…

MILPITAS, Calif.--(BUSINESS WIRE)-- #DiscoverAmazing--Amazfit, a leading global smart wearable brand owned by Zepp Health, today announced the T-Rex Ultra 2, the latest and most advanced member of its rugged T-Rex lineup. As part of the T-Rex family, the T-Rex Ultra 2 is built for uncertainty—designed to remain reliable in conditions where plans, environments, and outcomes are never fully defined. Purpose-built for…

Zepp Health receives a buy rating with a 1-year price target of $21.2, implying 22% upside from $18. Zepp Health posted 78.5% YoY revenue growth in Q3, driven by a shift to own-branded Amazfit products and improved operational efficiencies. Operating breakeven and narrowing net loss signal more sustainable earnings, while a share repurchase program highlights confidence in liquidity.

Zhongchao (NASDAQ: ZCMD - Get Free Report) and Zepp Health (NYSE: ZEPP - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, institutional ownership, valuation, dividends, earnings and profitability. Analyst Ratings This is a summary of recent